<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Applied Information Aspects of Medicine (Prikladnye informacionnye aspekty mediciny)</journal-id><journal-title-group><journal-title>Applied Information Aspects of Medicine (Prikladnye informacionnye aspekty mediciny)</journal-title></journal-title-group><issn publication-format="electronic">2070-9277</issn><publisher><publisher-name>Voronezh State Medical University named after N.N. Burdenko - The State Budgetary Institution of Higher Professional Education «Voronezh State Medical University named after N.N. Burdenko» of the Ministry of Public Health of the Russian</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1703</article-id><article-id pub-id-type="doi">10.18499/2070-9277-2014-17-1-171-177</article-id><article-categories><subj-group subj-group-type="heading"><subject>Conference Proceedings</subject></subj-group></article-categories><title-group><article-title>INFLUENCE OF RISK FACTORS ON THE OUTCOME OF CARDIOEMBOLIC STROKE</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Skorohodov</surname><given-names>A P</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hahanova</surname><given-names>O N</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Voronezh N.N. Burdenko State Medical Academy</aff><aff id="aff-2"></aff><pub-date date-type="epub" iso-8601-date="2014-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2014</year></pub-date><volume>17</volume><issue>1</issue><fpage>171</fpage><lpage>177</lpage><history><pub-date date-type="received" iso-8601-date="2020-04-24"><day>24</day><month>04</month><year>2020</year></pub-date></history><permissions><copyright-statement>Copyright © 2014, Прикладные информационные аспекты медицины</copyright-statement><copyright-year>2014</copyright-year></permissions><abstract>We examined 179 patients with acute cardioembolic stroke.The severity of neurological deficit was evaluated with the scale NIHSS and Rivermid. Diabetes and myocardial infarction in patients with cardioembolic stroke are the most unfavorable risk factors of death. In patients with atrial fibrillation defeat in the pool of the left middle cerebral artery was noted more frequently than in other basins. Average NIHSS score and scale Rivermid confirming the severity of neurological deficits, with different combinations of risk factors at the time of admission to hospital in patients who died was significantly higher than that of the discharged patients. Degree of neurological deficit at the time of admission was growing in proportion to the size of the infarct, which further influenced the outcome. Cardioembolic stroke with a larger focus of ischemia were significantly more often than with small and medium sized hearth cerebral ischemia. Psychosocial factors through a mechanism of acute and chronic distress may increase the risk of stroke, directly causing pathophysiological changes in the cardiovascular system. In addition, psychosocial factors may contribute to increased mortality rates from stroke through risk factors such as low physical activity, disorders of fat metabolism, tobacco, alcohol abuse, and generally unhealthy lifestyle.</abstract><kwd-group xml:lang="ru"><kwd>кардиоэмболический ишемический инсульт</kwd><kwd>факторы риска</kwd><kwd>прогноз инсульта</kwd><kwd>психосоциальные факторы</kwd><kwd>острый и хронический дистресс</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Гехт А.Б. Динамика клинических нейрофизиологических показателей у больных ишемическим инсультом в раннем восстановительном периоде. Дисс. д. м. н, М., 1993; 340 с.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Гусев Е.И., Виленский Б.С., Скоромец А.А., Бурд Г.С., Семенова Г.М., Скворцова В.И., Широков Е.А. Основные факторы, влияющие на исходы инсульта Журн. неврологии и психиатрии им. С.С.Корсакова, 1995, 95,1,4-7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Боголепова А.Н. Критерии диагностики и прогноза ишемического инсульта (клинико-нейропсихологическое обследование). Дисс. докт. мед. наук., М 2003; 289с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Terent A. Stroke morbidity. In : Whisnant J., editor. Stroke: populations, cohorts and clinical trials. Oxford, Boston, Butterworth-Heinemann, 1993; 37-58.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wolf P.A., D'Agostino R.B., O'Neal M.A., Sytkowski P., Kase C.S., Belanger A., Kannel W.B. Secular trends in stroke incidence and mortality the Framingham Study. Stroke, 1992,23, 1551-1555.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kelly-Hayes M., Wolf P.A., Kase C.S. et al. Time course of functional recovery after stroke: the Framingham Study. J Neurol Rehabil, 1989; 3: 65-70.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Eisenblatter D., Heinemann L., Claben E. // Stroke. - 1995. - V. 26. - P. 919-923.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Stone R. // Science. - 2000. - V. 288. - P. 1732-1733.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Andre-Petersson L., Engstrom G., Hagberg B. et al. // Stroke. - 2001. - V. 32. - P. 1712</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>May M., McCarron P., Stansfeld S., Ben-Shlomo Yo. // Stroke. - 2002. - V.33. - P. 7-13.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Truelsen T., Nilsen N., Boysen G., Gronbaek M. // Stroke. - 2003. - V. 34. - P. 856-860.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ohlin B., Nilsson P.M., Berglund G. // Eur. Heart J. - 2002. - V. 25, N 10. - P. 867-873.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Caroll D., Smith G.D., Sheffield D. et al. // BMJ. - 1995. - V. 310. - P. 771-775.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Everson S.A., Lynch J.W., Kaplan G.A. et al. // Stroke. - 2001. - V. 32. - P.1263-1270.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>May M., McCarron P., Stansfeld S., Ben-Shlomo Yo. // Stroke. - 2002. - V.33. - P. 7-13.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hart C.L., Hale D.J., Davey S.G. // Stroke. - 2000. - V. 32. - P. 2093-2097.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Martinez J., Pampalon R., Hamel D. // Chronic disease in Canada. - 2003. - V. 24, N</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Everson S.A., Roberts R.E., Goldberg D.E., Kaplan G.A. // Arch. Intern. Med. - 1998. - V. 158. - P. 1133-1138.</mixed-citation></ref></ref-list></back></article>
